Although promising in NOD mice, clinical trials focused on antigen-specific (insulin, GAD65) immunosuppression have failed to preserve insulin production in T1D patients, presumably because long-lasting tolerance to islet antigens was not induced [12, 13, 26]. The gene discussed is INS; the disease is type 1 diabetes mellitus.